HOME > BUSINESS > Article

Text Size

small

medium

large


Fujifilm to Make COVID-19 Vaccine Candidate for U.S. Firm

Fujifilm to Make COVID-19 Vaccine Candidate for U.S. Firm

   Tokyo, July 27 (Jiji Press)--A subsidiary of Japan's Fujifilm Corp. has won a contract to manufacture bulk drug substance for a coronavirus vaccine candidate developed by U.S. biotechnology firm Novavax Inc.
   The subsidiary, Fujifilm Diosynth Biotechnologies, has already started production of the first batch of the vaccine candidate.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Approval Rating for Abe Cabinet Drops to 32.7% in Aug., 2nd Worst after 29.9%
ECONOMY
About 40% of Employees to Leave Ailing Electronics Retailer Laox
SPORTS
Golf Women: Shibuno Comes Tentative 126th on Suspended Scottish Open Day One
OTHER
1st-Ever 1945 A-Bombing Exhibition in Hawaii Open on Battleship Missouri

AFP-JIJI PRESS NEWS JOURNAL


Photos